BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20191986)

  • 1. [Clinical predictors of ventricular arrhythmia storms in Chagas cardiomyopathy patients with implantable defibrillators].
    Flores-Ocampo J; Nava S; Márquez MF; Gómez-Flores J; Colín L; López A; Celaya M; Treviño E; González-Hermosillo JA; Iturralde P
    Arch Cardiol Mex; 2009; 79(4):263-7. PubMed ID: 20191986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of arrhythmic storm in implantable defibrillator patients.
    Krivan L; Kozák M; Sepsi M; Svobodník A; Spinar J
    Med Sci Monit; 2005 Sep; 11(9):CR426-9. PubMed ID: 16127361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America.
    Muratore CA; Batista Sa LA; Chiale PA; Eloy R; Tentori MC; Escudero J; Lima AM; Medina LE; Garillo R; Maloney J
    Europace; 2009 Feb; 11(2):164-8. PubMed ID: 19056745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electrical storms in patients with implantable cardioverter-defibrillator: incidence and clinical management].
    Devecchi P; Plebani L; Occhetta E; Bortnik M; Francalacci G; Magnani A; Marino P
    G Ital Cardiol (Rome); 2006 Oct; 7(10):695-701. PubMed ID: 17171993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Electrical storm in patients with implantable cardioverter-defibrillator].
    Bárzaga FJ; Clavijo PC; Sánchez MD; Hevia JC; Molina RZ; Pérez MA; Leza JB; Rodríguez YF; Balea FD
    Arch Cardiol Mex; 2008; 78(1):68-78. PubMed ID: 18581715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
    Healey JS; Hallstrom AP; Kuck KH; Nair G; Schron EP; Roberts RS; Morillo CA; Connolly SJ
    Eur Heart J; 2007 Jul; 28(14):1746-9. PubMed ID: 17283003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators.
    Brigadeau F; Kouakam C; Klug D; Marquié C; Duhamel A; Mizon-Gérard F; Lacroix D; Kacet S
    Eur Heart J; 2006 Mar; 27(6):700-7. PubMed ID: 16421175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and predictors of electrical storm in patients with implantable cardioverter-defibrillator.
    Arya A; Haghjoo M; Dehghani MR; Fazelifar AF; Nikoo MH; Bagherzadeh A; Sadr-Ameli MA
    Am J Cardiol; 2006 Feb; 97(3):389-92. PubMed ID: 16442402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
    Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
    Fuchs T; Groysman R; Meilichov I
    Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients < 75 and patients >or= 75 years of age treated with implantable cardioverter defibrillators.
    Ermis C; Zhu AX; Vanheel L; Sakaguchi RN; Lurie KG; Lu F; Benditt DG
    Europace; 2007 May; 9(5):270-4. PubMed ID: 17371804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Specific complications in the treatment with implantable cardioverter-defibrillators].
    Krivan L; Kozák M; Sepsi M; Svobodník A; Spinar J
    Cas Lek Cesk; 2004; 143(8):521-5; discussion 526-7. PubMed ID: 15446455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrical storm in patients with biventricular implantable cardioverter defibrillator: incidence, predictors, and prognostic implications.
    Gasparini M; Lunati M; Landolina M; Santini M; Padeletti L; Perego G; Vincenti A; Curnis A; Carboni A; Denaro A; Spotti A; Grammatico A; Regoli F; Boriani G;
    Am Heart J; 2008 Nov; 156(5):847-54. PubMed ID: 19061697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
    Zareba W; Piotrowicz K; McNitt S; Moss AJ;
    Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
    Desai AD; Burke MC; Hong TE; Kim S; Salem Y; Yong PG; Knight BP
    J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm.
    Verma A; Kilicaslan F; Marrouche NF; Minor S; Khan M; Wazni O; Burkhardt JD; Belden WA; Cummings JE; Abdul-Karim A; Saliba W; Schweikert RA; Tchou PJ; Martin DO; Natale A
    J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1265-70. PubMed ID: 15574176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of all-cause 1-year mortality in implantable cardioverter defibrillator patients with chronic Chagas' cardiomyopathy.
    di Toro D; Muratore C; Aguinaga L; Batista L; Malan A; Greco O; Benchetrit C; Duque M; Baranchuk A; Maloney J
    Pacing Clin Electrophysiol; 2011 Sep; 34(9):1063-9. PubMed ID: 21535031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm.
    Streitner F; Kuschyk J; Veltmann C; Ratay D; Schoene N; Streitner I; Brueckmann M; Schumacher B; Borggrefe M; Wolpert C
    Cytokine; 2009 Sep; 47(3):166-72. PubMed ID: 19604708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
    J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.